

Lifecore stock plunges after earnings miss and weak 2026 outlook, with customer losses and delayed growth plans weighing on shares.
You can purchase shares of Lifecore Biomedical (NASDAQ:LFCR) through any online brokerage.
Other companies in Lifecore Biomedical’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Waters Corp (NYSE:WAT), Agilent Technologies Inc (NYSE:A) and IQVIA Holdings Inc (NYSE:IQV).
Lifecore Biomedical has a consensus price target of $8.00.
The stock price for Lifecore Biomedical (NASDAQ: LFCR) is $6.39 last updated November 17, 2026 at 4:00 PM EST.
There are no upcoming dividends for Lifecore Biomedical.
Lifecore Biomedical does not have any upcoming earnings scheduled.
There is no upcoming split for Lifecore Biomedical.
Lifecore Biomedical is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and...